This site is intended for health professionals only
Tuesday 23 October 2018
Share |

Topic: *** Editor's Pick

October 17, 2018

The Child health in 2030 in England: comparisons with other wealthy countries report, published [15 October] by the Royal College of Paediatrics and Child Health (RCPCH), compared England with European and other western countries known as the EU15+.
 
Researchers used long-term historical data to project outcomes for children and young people’s health in 2030.
 

October 17, 2018

Eli Lilly and Company announced today that the European Commission has granted marketing authorisation (MA) for Verzenios® (abemaciclib) for the treatment of women with hormone receptor-positive (HR+), epidermal growth factor receptor 2 negative (HER2-) locally advanced or metastatic breast cancer, in combination with an aromatase inhibitor (AI) or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy.1
 

October 17, 2018

Pharmacists must implement new validation processes from today (17 October) to prioritise the limited stocks of EpiPen junior 150 microgram (mcg), the Department of Health and Social Care (DHSC) and NHS England have said.

Following ‘critical’ shortages of the device, the DHSC and NHS England asked pharmacists to validate both private and NHS prescriptions before ordering and supplying the device to a patient.

October 17, 2018

Pregabalin and gabapentin will be reclassified as class C drugs next year following a rising numbers of deaths linked to the drugs, the UK Government has said.
 

October 12, 2018

Lab solutions company Roche Diagnostics has launched a new business unit called Roche Healthcare Consulting. 
 
The new unit will focus on digital diagnostics and help laboratories, hospitals and other healthcare providers to “optimise their performance”.
 
The global consulting service will feature over 250 experienced consultants who specialise in business, healthcare and technology, and will use data analytics and reports to help clients improve their operational, clinical and financial performance.
 

October 11, 2018

A one-off DNA test could spot people at risk of a heart attack in adulthood much earlier in life for just £40, according to new research.
 
The study, part-funded by the charity the British Heart Foundation and published in the Journal of the American College of Cardiology, developed a new scoring system to identify those at risk because of their genetics.
 
It costs £40, making it a “cost effective” way of helping preventing heart disease according to the report’s authors.
 

October 9, 2018

Women with urinary incontinence should only be offered mesh surgery as a last resort, according to new draft guidelines.
 
The full range of non-surgical options should be offered to women who have urinary incontinence and pelvic organ prolapse before any operations, said the National Institute for Health and Care Excellence (NICE).
 
For urinary incontinence, lifestyle interventions, physical therapies, behavioural therapies and medicines should be considered before surgery.
 

October 3, 2018

The Nobel prize for physiology or medicine has gone to two scientists who have discovered how to fight cancer using the body’s immune system.
 
Professor James Allison from the University of Texas and Professor Tasuku Honjo from Kyoto University were awarded the prize for their ‘discovery of cancer therapy by inhibition of negative immune regulation’.
 
Their research has led to treatments for advanced skin cancer, which experts have said has proved to be ‘strikingly effective’.
 

October 2, 2018

An emergency £240m cash injection will be given to the social care sector in the UK to help ease the pressure on the NHS this winter.
 
The funding will be routed through local councils and will be spent on packages of care to free up hospital beds, either through enabling people to go home quickly, or preventing older people from coming into hospital unnecessarily.
 
The plans are set to be announced today by health secretary Matt Hancock at the Conservative party conference in Birmingham.
 

October 2, 2018

Patients with severe allergies can use certain batches of EpiPen four months after their expiry date, the Government has said.
 
In a supply alert issued last week (28 September), the Department of Health and Social Care (DHSC) said that patients can use some batches of EpiPen and EpiPen Junior, due to "limited availability for the remainder of 2018".
 
"Limited availability"
 

September 28, 2018

Hannah Beba is a senior pharmacist practising in the diabetes and endocrinology fields at the County Durham and Darlington NHS Foundation Trust. She is also one of the charity Diabetes UK clinical champions and an independent prescriber.
 
She talks to Léa Legraien about her successes, challenges and love for the profession.
 
 
Q Why did you become a pharmacist?
 
 

September 27, 2018

An award winning hospital team dedicated to tackling antimicrobial resistance talk about their efforts to tackle this issue and why staff engagement is essential to running a successful programme
 
Hala Kandil, microbiology consultant and antimicrobial resistance (AMR) lead, and Tejal Vaghela, lead antimicrobial pharmacist work together at Hertfordshire Hospitals NHS Trust in the UK to help tackle antimicrobial resistance.
 

September 26, 2018

Clinical education research pharmacist Michael Lloyd shares his pharmacy journey
 
Undergraduate experiences developed an interest in quantitative research, with my early career seeing involvement in many audits and quality improvement projects. I later completed a postgraduate Master’s degree that illuminated the world of qualitative methodologies and I was hooked!
 
 

September 21, 2018

The European Commission (EC) had approved the use of BRAFTOVI (encorafenib) and MEKTOVI (binimetinib) to treat adults with advanced BRAF-mutant melanoma.
 
The EC’s decision is based on results from the Phase 3 COLUMBUS trial, which demonstrated 14.9 months median progression-free survival and 33.6 months median overall survival with the combination therapyversus vemurafenib monotherapy with 7.3 and 16.9 months, respectively.
 

September 7, 2018

A ‘hard look’ at gender parity issues will be vital as the proportion of women working in pharmacy increases, a representative body for the sector has warned.
 

September 7, 2018

Pharmacists could do more to empower female carers, a representative body for the sector has urged.
 
A report published yesterday (3 September) by the International Pharmaceutical Federation (FIP) showed that pharmacists are in an ‘ideal position to empower’ informal women caregivers.
 
The news comes while the FIP holds its 78th annual World Congress of Pharmacy and Pharmaceutical Sciences in Glasgow, from 2 to 6 September.
 
‘Key’ relationship

September 7, 2018

Six in 10 pharmacy professionals are against the sale and dispensing of homeopathic products, pharmacists at an international conference have heard.

September 7, 2018

Along with a varied and rewarding pharmacy career, I have enjoyed the last 22 years caring for older people living in community and care home settings.  My greatest motivation and the essence of my role is improving the outcomes and experience of older people through the best use of medicines. 
 

August 30, 2018

The European Commission has approved Vyxeos 44 mg/100mg powder for concentrate for solution for infusion for the treatment of adults with newly-diagnosed, therapy-related acute myeloid leukaemia (t-AML) or AML with myelodysplasia-related changes, manufacturer Jazz Pharmaceuticals has announced.
 
Vyxeos is an advanced liposomal formulation that delivers a synergistic molar ration of daunorubicin and cytarabine, Jazz Pharmaceuticals said.
 
The EC approval extends to all European member states as well as Iceland, Norway sand Liechtenstein.

August 30, 2018

Novartis UK Oncology statement on Novartis receiving European Commission approval of its CAR-T cell therapy, Kymriah® (tisagenlecleucel)

August 24, 2018

Kathy Oxtoby looks at the effects of antimicrobial resistance across Europe will be if it goes unchecked and investigates what should be done to tackle it
 
It may be a natural phenomenon, but antimicrobial resistance (AMR) has become a global health crisis of similar importance to infectious-disease pandemics, according to the World Health Organization (WHO).
 

August 24, 2018

Working as a pharmacist in the Central African Republic and the Democratic Republic of the Congo was a rewarding experience, despite considerable challenges, explains Barbara Pawulska
 
What with busy dispensaries and tricky patients to contend with, life as a pharmacist can present challenges in any walk of the profession.
 

August 14, 2018

Only one third of pharmaceutical companies are compliant with Europan anti-counterfeiting measures, according to a representative group.
 
In a letter sent last week (6 August), the European Medicines Verification Organisation (EMVO) said that of the 2,291 pharmaceutical companies that have to connect to the European Medicines Verification System (EMVS) in less than six months, only 841 (36%) have signed the required agreement. 
 

August 9, 2018

New restricted indications on prescribing Esmya (ulipristal acetate) for symptoms of uterine fibroids put in place by the UK’s medicines watchdog now replace instructions that the drug should not be prescribed to any new patients.